The sale is tied to RSU vesting and tax withholding, not a discretionary insider sell-off. Monitor for any subsequent Form 4 filings to confirm execution, but no material signal for the stock.
Price Chart
Executive Summary
Chris Degnan, an officer of UroGen Pharma, filed a Form 144 on October 9, 2026, indicating intent to sell 2,202 ordinary shares valued at approximately $89,621. The shares were issued upon vesting of RSUs, and the sale is described as covering tax withholding obligations. This is a routine insider sale for tax purposes, not a discretionary liquidation of holdings.
Key Facts
- Insider: Chris Degnan (Officer)
- Shares to be sold: 2,202 ordinary shares
- Estimated value: $89,621.40
- Date of filing: October 9, 2026
- Sale reason: Shares issued upon vesting of RSUs; sold to cover tax withholding obligations
- Broker: Oppenheimer & Co. Inc.
- Market: Nasdaq
Financial Impact
Approximately $89,621 in shares proposed for sale, representing a small fraction of the company's market cap.
Risk Factors
- Insider selling for tax purposes is routine and not indicative of negative outlook.
- No additional context from the filing suggests a change in company fundamentals.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001976408-26-000887 |
| Document: 0001976408-26-000887-index.html | 0001976408-26-000887 |
| Document: 0001976408-26-000887.txt | 0001976408-26-000887 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 1d ago | SC 13G/A | $34.16 | awaiting T+5 | awaiting T+5 | $34.09 (−0.20%) |
Oct 19, 2026 10d ago | Press Release | $34.15 $34.23 | ▲ +0.23% | ▲ +0.38% | $34.09 (−0.18%) |
Oct 9, 2026 20d ago | 144 | $36.83 $34.56 | ▼ −6.16% | ▼ −4.20% | $34.09 (−7.44%) |
Sep 9, 2026 7w ago | Insider Cluster | $45.00 $43.04 | ▼ −4.36% | ▼ −4.02% | $34.09 (−24.24%) |
Aug 20, 2026 10w ago | 8-K | $46.80 $45.50 | ▼ −2.78% | ▼ −3.89% | $34.09 (−27.16%) |
Aug 5, 2026 12w ago | 8-K | $46.43 $49.00 | ▲ +5.54% | ▲ +5.18% | $34.09 (−26.58%) |
Jun 23, 2026 18w ago | 8-K | $35.42 $37.94 | ▲ +7.11% | ▲ +5.41% | $34.09 (−3.75%) |
Jun 2, 2026 21w ago | 8-K | $26.54 $28.18 | ▲ +6.18% | ▲ +9.14% | $34.09 (+28.45%) |
May 6, 2026 25w ago | Press Release | $26.25 $29.80 | ▲ +13.52% | ▲ +12.39% | $34.09 (+29.87%) |
Apr 29, 2026 26w ago | Press Release | $23.34 | awaiting T+5 | awaiting T+5 | $34.09 (+46.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers